Published in Lancet on October 30, 2010
Intensive treatment of hyperglycaemia: ACCORD. Lancet (2010) 1.43
Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev (2008) 3.11
Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care (2004) 3.02
Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70
Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol (2006) 2.70
Global health learning outcomes for medical students in the UK. Lancet (2011) 2.68
The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet (2004) 2.59
Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care (2012) 2.32
The association between birth weight and capillary recruitment is independent of blood pressure and insulin sensitivity: a study in prepubertal children. J Hypertens (2002) 2.03
The myth of the metabolic syndrome. Diabetologia (2005) 2.01
Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab (2002) 1.95
Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A (2007) 1.92
Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care (2007) 1.92
International health graduates--career path experience. Lancet (2012) 1.91
A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe? Diabetes Care (2013) 1.90
Troglitazone: the lesson that nobody learned? Diabetologia (2006) 1.79
Postgraduate training in global health: ensuring UK doctors can contribute to health in resource-poor countries. Clin Med (2011) 1.78
Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care (2005) 1.78
Diabetes care in sub-Saharan Africa. Lancet (2006) 1.72
Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination. Diabetes Care (2003) 1.71
Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab (2004) 1.60
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis (2002) 1.60
Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res (2003) 1.48
The Y-Y paradox. Lancet (2004) 1.44
Conflicts of interest in guideline panel members. BMJ (2011) 1.43
International Health Electives: Four years of experience. Travel Med Infect Dis (2004) 1.38
Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab (2009) 1.29
Regional body composition as a determinant of arterial stiffness in the elderly: The Hoorn Study. J Hypertens (2004) 1.28
Can we change the course of beta-cell destruction in type 1 diabetes? N Engl J Med (2002) 1.24
Conceptualising global health: theoretical issues and their relevance for teaching. Global Health (2012) 1.22
Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation (2007) 1.18
The evolution of global health teaching in undergraduate medical curricula. Global Health (2012) 1.17
Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings. Diabetes Res Clin Pract (2010) 1.14
Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem? Diabetes (2010) 1.13
Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes (2012) 1.13
Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'. BMC Health Serv Res (2006) 1.05
High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes (2002) 1.04
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care (2004) 1.03
Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke (2003) 0.98
Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep (2011) 0.97
Intensified glucose control in type 2 diabetes--whose agenda? Lancet (2010) 0.96
Metformin and its liver targets in the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord (2003) 0.95
Association of intercellular adhesion molecule-1 gene with type 1 diabetes. Lancet (2003) 0.95
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J (2005) 0.94
Insulin glargine and cancer: another side to the story? Lancet (2009) 0.94
Survival of the fittest? Natural selection in islet transplantation. Transplantation (2005) 0.92
The market in diabetes. Diabetologia (2006) 0.92
On the road to the insulin centenary. Lancet (2012) 0.92
Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci (2003) 0.91
Comparison between Long-Menu and Open-Ended Questions in computerized medical assessments. A randomized controlled trial. BMC Med Educ (2006) 0.91
Access to medicines versus access to treatment: the case of type 1 diabetes. Bull World Health Organ (2008) 0.91
GLP-1-based therapies and the exocrine pancreas: more light, or just more heat? Diabetes (2012) 0.90
Diabetes in Kyrgyzstan: changes between 2002 and 2009. Int J Health Plann Manage (2012) 0.89
Aspirin in diabetic retinopathy. A systematic review. Endocrinol Metab Clin North Am (2002) 0.89
Licensing drugs for diabetes. BMJ (2010) 0.88
Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. J Clin Endocrinol Metab (2006) 0.88
Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care (2003) 0.87
Activated protein C downregulates p38 mitogen-activated protein kinase and improves clinical parameters in an in-vivo model of septic shock. Thromb Haemost (2007) 0.87
Body weight, blood pressure, and mortality in a cohort of obese patients. Am J Epidemiol (2002) 0.86
Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev (2014) 0.85
GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm. BMJ (2013) 0.85
Preventing stroke with ramipril. Superiority of particular class of antihypertensive agent remains to be shown. BMJ (2002) 0.85
Islet autoimmunity in children with Down's syndrome. Diabetes (2006) 0.85
Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years. Diabetes (2004) 0.85
The International Diabetes Federation: losing its credibility by partnering with Nestlé? Lancet (2012) 0.84
A prospective study comparing operative time in conventional laparoscopic and robotically assisted Thal semifundoplication in children. J Pediatr Surg (2006) 0.84
Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovasc Diabetol (2012) 0.83
Gridlocked guidelines for diabetes. Lancet (2010) 0.83
Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial. Int J STD AIDS (2013) 0.83
Conventional and novel cardiovascular risk factors and markers of vascular damage in rural and urban Indian men. Int J Cardiol (2011) 0.83
Twinning for better diabetes care: a model for improving healthcare for non-communicable diseases in resource-poor countries. Postgrad Med J (2009) 0.82
Is puberty an accelerator of type 1 diabetes in IL6-174CC females? Diabetes (2005) 0.82
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost (2004) 0.81
TNF-alpha levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-alpha and insulin resistance. Clin Sci (Lond) (2006) 0.81
Maternal age and diabetes in childhood. BMJ (2010) 0.81
Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev (2015) 0.80
'Hard,' 'soft' and 'surrogate' endpoints in diabetes. J Epidemiol Community Health (2012) 0.79
Therapy: The second time as farce: rosiglitazone and the regulators. Nat Rev Endocrinol (2010) 0.79
Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene. Atherosclerosis (2003) 0.79
Life-course socio-economic factors, skin colour and abdominal obesity in adulthood in a Brazilian birth cohort. Public Health Nutr (2009) 0.79
Post-load hyperglycaemia-an inappropriate therapeutic target. Lancet (2002) 0.79
Can NICE prevent diabetes? Heart (2013) 0.79
Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women. Diabetologia (2015) 0.78
Confounders in chronic stress at work and metabolic syndrome. BMJ (2006) 0.77
Hyperglycaemia as a cardiovascular risk factor in diabetes. Lancet (2008) 0.77
Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review. Leuk Lymphoma (2013) 0.77
European Medicines Agency must take account of cardiovascular harm associated with degludec insulin. BMJ (2013) 0.76
What are editors for? Lancet (2012) 0.76
Glucagon-like peptide-1 drugs. Use of GLP-1 analogues needs great caution. BMJ (2011) 0.76
Commentary: Politics of affordable insulin. BMJ (2011) 0.76
Infant diets and type 1 diabetes: too early, too late, or just too complicated? JAMA (2003) 0.76
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Database Syst Rev (2016) 0.76
Perivascular fat in human muscle. Lancet Diabetes Endocrinol (2016) 0.76
The DREAM trial. Lancet (2006) 0.75
Prognosis of diabetes in the developing world. Lancet (2003) 0.75